For years, American individuals living with diabetes faced severe challenges due to the escalating cost of insulin, which saw a threefold increase from 2002 to 2013, surpassing the rate of inflation. Recently, however, the 2022 Inflation Reduction Act, passed by the US Congress and endorsed by the Biden administration, has led to a positive shift. …